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ABSTRACT Partial amino acid sequences of the Ia mole-
cule encoded by the I-E or IC (I-EC) subregion of the major
histocompatibility complex of the mouse are presented. The Ia
molecule appears to be comprised of two noncovalently asso-
ciated polypeptides. The larger subunit, a, has an approximate
molecular weight of 35,000 and the smaller subunit, f, an ap-
proximate molecular weight of 28,000. Several interesting
homology relationships (or the lack thereof) are apparent when
the Ta polypeptides from the I-EC subregion are compared both
with their counterarts from man and guinea pig and with the
molecules encoded in the I-A subregion. Clearly the most im-
pressive homology relationship is that seen between the a
polypeptide from the I-EC subregion of mouse and its human
counterpart. This is in striking contrast to the P polypeptide,
which bears no apparent homology to its human counterpart.
The major histocompatibility complex (H-2 complex) of the
mouse is a genetic region that encodes a variety of cell-surface
antigens, many of which seem interrelated with the immune
response. Loci that map in the I region of the H-2 complex
control a series of phenotypic traits that are intimately involved
in the vertebrate immune response (1): immune responsiveness
to particular antigens (2); cellular interactions among T cells,
B cells, and macrophages (3-5); B-cell differentiation (6); and
helper or suppressor factors for the immune response (7, 8).
The only gene products from I region loci that have been
directly identified with alloantisera are the Ta (I region asso-
ciated) antigens. Ta molecules are highly polymorphic (9, 10)
and are expressed on immunocompetent cells (B lymphocytes,
T lymphocytes, and macrophages) and on epidermal cells (11).
The relationship between Ta molecules and the phenotypic traits
controlled by the I region is not clear. Indirect evidence suggests
that the Ta gene products mediate at least some of the immu-
nological phenomena controlled by the genes of the I region
in that antisera against Ta inhibit antibody responses in vitro
(12), inhibit antigen-induced T-cell proliferation (13), remove
antigen-specific T-cell factors (7, 8, 14), and selectively kill (in
the presence of complement) lymphocytes that perform dif-
ferent immunological functions (6, 15).
The I region of the H-2 complex has been subdivided by
recombinational analysis into five subregions, designated I-A,
I-B, I-J, I-E and I-C (16, 17). Three Ta loci (Ia-l, Ia-5, and Ia-3)
mark the subregions I-A, I-E, and I-C, respectively. The
products of these loci, the Ta antigens, are integral cell-surface
glycoproteins (18, 19). In the mouse, Ta antigens generally have
two subunits, one approximately 35,000 in molecular weight
(a) and one approximately 28,000 (fl), that are noncovalently
associated (20-22). It is not known whether antisera against Ta
recognize one or both subunits. Human Ta molecules isolated
from lymphoblastoid cell lines exhibit a similar structure (23).
Ta molecules isolated from the spleen cells of guinea pigs have
three distinct molecular structures: a and # components non-
covalently associated; a and (3 components disulfide linked, and
one or two # components (24).
Because of the genetic and phenotypic complexity of the H-2
complex, detailed analyses of its gene products have been dif-
ficult to carry out. One fruitful approach has been the use of
the recently developed microsequence techniques for the
analysis of picomole quantities of polypeptides. Partial amino
acid sequence analyses of the transplantation antigens from
mice (25-28), humans (29,30), and guinea pigs (M. McMillan,
B. D. Schwartz, M. J. Waxdal, E. M. Shevach, W. E. Paul, and
L. Hood, unpublished data) have demonstrated striking se-
quence homologies and have raised provocative and intriguing
questions about the genetic organization and evolutionary or-
igins of the genes that encode these antigens (31).
Partial amino acid sequence comparisons have also been
made among certain Ta polypeptides from humans (32), guinea
pigs (33), and I-A subregion of the mouse H-2 complex (21, 22).
Tentative amino acid sequence homologies were noted between
the human and guinea pig (3 polypeptides. No homologies were
demonstrable when a and ,Bpolypeptides from humans and a
, polypeptide from guinea pigs were compared to their mouse
I-A region counterparts.
In'this paper we present partial amino acid sequence data
on a and , polypeptides coded by the I-E or I-C (I-EC)
subregion of the mouse H-2 complex. The new data demon-
strate that striking homology exists between the a polypeptide
of mice and the larger Ta polypeptide (p34) of humans. This
striking homology is absent when the ( polypeptide of mice is
compared to the smaller Ta polypeptide (p29) of humans. We
have published a preliminary report of the a polypeptide se-
quence elsewhere (22).
MATERIALS AND METHODS
Mice and Antisera. The genetic constitutions of the mice
used in the preparation of the alloantiserum and in the isolation
of the Ta antigens are given in Table 1.
Isolation of Ia Antigens. Splenic lymphocytes (2 X 108) were
incubated for 5 hr in 4 ml of Hanks' balanced salt solution with
10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(Hepes), 5% dialyzed fetal calf serum, and 1 mCi each of tri-
tiated alanine, tyrosine, valine, isoleucine, phenylalanine, and
leucine. The cells were then lysed with 4 ml of 10mM Tris/0.15
M NaCI/0.5% Triton X-100 at pH 7.4. The debris was removed
by centrifugation. The supernatant containing the radiolabeled
Ta antigens was incubated with the specific alloantiserum and
the resulting immune complexes were precipitated by either
the gamma globulin fraction of rabbit anti-mouse IgG or by
Abbreviations: NaDodSO4, sodium dodecyl sulfate; PTH-amino acid,
phenylthiohydantoin-amino acid; I-EC, I-E or I-C.
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Table 1. Genetic constitution of recipient-donor-target
strain combinations of mice used to prepare
alloantiserum and Ia polypeptides
Regions of H-2*
Haplo- K S D
Strain type A B J E C
A.TH (recipient) t/2 s s s s s s s d
A.TL (donor) t/1 s k k k k k k d
BIO.HTT (target) t/3 s s s s k k k d
* Boxed regions indicate specificity of antiserum against target.
Staphylococcus aureus (34, 35). The immunoprecipitates were
run on 10% sodium dodecyl sulfate (NaDodSO4)/polyacryl-
amide gels. The Ia polypeptides were eluted from the gels,
mixed with 2 mg of carrier ovalbumin, lyophilized, and di-
alyzed extensively against 0.001% NaDodSO4.
Microsequence Analysis. The a and fd polypeptides were
each submitted to automatic sequence analysis twice with 2 mg
of sperm whale apomyoglobin each time as a carrier and to
monitor the performance of the sequenator. In one run, a
Beckman model 890A sequenator was used and the individual
labeled phenylthiohydantoin (PTH)-amino acid derivatives
were separated on a Waters Associates high-pressure liquid
chromatograph. In the second run, the Beckman model 890A
sequenator had been modified as described by Wittman-Lie-
bold (36). The labeled PTH derivatives were separated on a Du
Pont 830 high-pressure liquid chromatograph with a Zorbax
O.D.S. column. The radioactivity of the individual labeled
PTH-amino acids fractions was determined on a Beckman
model LS 230 scintillation counter.
RESULTS AND DISCUSSION
Ia Molecules of Different Subregions of Mice Exhibit
Structural Similarities. The A.TH anti-A.TL antiserum, when
tested against B10.HTT lysates, has potential reactivity with
gene products encoded by the S and G (not shown) regions of
the H-2 complex as well as the I-E and I-C subregions. Since
Ia-like membrane antigens have not been demonstrated for the
S or G regions in lymphocytes, this antiserum is probably re-
acting principally with I region molecules. Our antiserum
cannot distinguish between molecules coded by the I-Ek or ICk
subregions, and we will denote this ambiguity as the I-ECk
subregion.f The two Ia polypeptides isolated by using this an-
tiserum appear to be noncovalently associated because they
migrate as two components on NaDodSO4/polyacrylamide gel
electrophoresis under reducing and nonreducing conditions.
A typical gel profile is shown in Fig. 1. The larger component,
designated a, migrates with an apparent molecular weight of
35,000, whereas the smaller component, denoted ,B, migrates
with an apparent molecular weight of 28,000. These compo-
nents migrate as relatively broad peaks, often with shoulders
on them. This molecular weight heterogeneity may be due to
the presence of additional polypeptides that have blocked NH2
termini, or alternatively it may have its origins in carbohydrate
heterogeneity or in complexities, not as yet understood, in the
An informal nomenclature committee at the Ir Gene Workshop at
Asilomar in December, 1976, suggested that the Ta polypeptides of
the mouse should be designated by a capital letter denoting the ap-
proprate subregion with the haplotype designated by a superscript
and the subunit component by a subscript. Thus the a polypeptide
isolated from the I-A subregion of mice carrying the H-2k haplotype
would be denoted A.. The larger component of the human Ta mol-
ecule is designated p34 (polypeptide of 34,000 molecular weight),
whereas the smaller component is designated p29.
U
-43015e
,I
a 9 -i
1400
1200
E 1000Q
I 800
600
400
200
10 30 50 70
Migration distance, mm
90
FIG. 1. NaDodSO4/polyacrylamide electrophoresis pattern of
I-ECk Ia molecules under reducing conditions. Migration distance
in the gel is plotted on the abscissa and radioactivity of tritiated amino
acids incorporated into protein is plotted on the ordinate. Staphy-
lococcus aureus was used in this precipitation. Peak at 90mm = 3015
cpm.
serology of the I region. However, since our antiserum puta-
tively detects gene products encoded in the I-EC subregion, we
tentatively conclude that the products we have isolated are Ia
antigens. The Ia molecules encoded in the I-EC subregion, as
well as those coded by the I-A subregion of mice appear to have
a and ,B polypeptides of similar molecular weights. Thus, the
Ta molecules from mice, humans, and guinea pigs demonstrate
homology in their gross polypeptide structures.
Microsequence Analysis of Ia Molecules. The repetitive
yields of the carrier myoglobin throughout these runs ranged
between 90 and 95%. The repetitive yields of the Ta polypep-
tides..were comparable to those of their myoglobin carrier.
Typical amino acid sequence data obtained by the micro-
sequencing technique are illustrated in Fig. 2. The sequence
data from the Ta molecules exhibit a peculiarity not present in
the application of this methodology to the presumably homo-
geneous H-2K and H-2D transplantation antigens in that minor
peaks of radioactivity are sometimes observed, occasionally
distributed over several residues. The same peculiarity was
observed with the I-A subregion polypeptides (22). It is quite
possible that these minor peaks of radioactivity result from
unresolved technical problems. Alternatively, they may reflect
heterogeneity in the Ia polypeptides. In this regard, it is inter-
esting to note that with the admittedly limited number of
residues incorporated into these polypeptides, we have never
identified two major residues at a single position. Thus, a single
major sequence is clearly discernible from these data (Table 2).
However, because of the minor peaks and the limited sequence
data available, no firm conclusions can be reached about the
heterogeneity (or homogeneity) of Ia molecules.
One technical point should be stressed. During the produc-
tion of the PTH-isoleucine residues, some isomerization to
PTH-allo-isoleucine occurs (37). PTH-allo-isoleucine cochro-
matographs with PTH-phenylalanine under the conditions of
high-pressure liquid chromatography. Thus, PTH-isoleucine
also appears in the PTH-phenylalanine portion of the high-
pressure liquid chromatogram (see Fig. 2, compare the iso-
leucine at positions 1, 7, and 8 with the phenylalanine at position
12).
The partial NH2-terminal amino acid sequences of several
Ia polypeptides from mice, humans, and guinea pigs are shown
in Table 2. Three types of amino acid data are presented. (i) At
certain positions major residues are unambiguously identified
(e.g., tyrosine at position 13 in ECk). (ii) At other positions
positive identification has not been made although we are
certain that the residue(s) identified in other Ia polypeptides
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FIG. 2. (Left) Amino acid sequence data from the EC,' polypep-
tide. (Right) Amino acid sequence data from the ECk polypeptide.
Residue number is plotted on the abscissa and the radioactivity of
individual tritiated PTH-amino acids is plotted on the ordinate. We
have assigned residues using the following criteria: (i) A sharp rise in
radioactivity at one position is followed by a more gradual decline at
subsequent positions, e.g., Ala at position 10 in the a polypeptide. (ii)
The amount of radioactivity in a particular PTH-residue must be
comparable in the a and # polypeptides, i.e., Tyr at position 13 in the
a polypeptide and Tyr at position 11 in the ft polypeptide. We do not,
therefore, assign Ile at position 7 in the fi molecule because it is less
than 25% that of the Ile residues in the a polypeptide. We believe there
is a Leu at position 9 in the fl molecule (the counts between a and ft
are comparable in two sequence runs) but have not assigned it due
to technical difficulties in one run. (iii) All assigned peaks of radio-
activity must conform to the 90-95% repetitive yield observed for
myoglobin, e.g., Phe at positions 8 and 18 in the # molecule. We do not,
therefore, assign Phe at position 12 or Valor Tyr at position 5 in the
fBmolecule. We believe these small peaks of radioactivity are due to
minor components or to unidentified technical difficulties.
is not present at this same position in a particular component.
This is indicated by a dash (e.g., there is no tyrosine at position
16 in ECk). (iii) Finally, there are positions in which no residue
has been identified (e.g., position 2 in ECU). These data are very
limited in nature, but they do allow us to draw certain pre-
liminary conclusions about homology relationships among the
various Ia genes.
Partial Amino Acid Sequence Analyses Can Reveal Three
General Types of Homology Relationships. To illustrate the
types of conclusions we will draw from our data, the NH2-ter-
minal sequences of three known pairs of proteins of varying
relatedness are given in Table 3. Below the complete sequences
are partial sequences which would be obtained using the
methodology employed in this paper. Three points can be made
about these partial sequence comparisons.
First, the human and mouse (32-microglobulin are highly
homologous with -80% sequence identity over their NH2-
terminal 18 residues. Five out of seven residues (-70%) are
identical in the partial sequence comparisons (see boxed resi-
dues in Table 3). Second, human ,32-microglobulin and a con-
stant region homology unit from the heavy immunoglobulin
chain show -34% identity after the appropriate placement of
sequence insertions or deletions. Since sequence gaps cannot
be placed in partial amino acid sequences, only 1/7 ('15%) of
the residues that can be compared are identical. Thus low levels
of sequence identity may indicate low levels of homology or
it may represent a statistical fluctuation in the comparison of
two unrelated samples. Finally, two unrelated proteins, human
02-microglobulin and lysozyme, with less than 10% identity
overall, show no identities in nine residues compared. Thus
partial sequence data reveal three general types of homology
relationships with somewhat arbitrary boundaries-striking
sequence homology (50% or greater), questionable homology
(10-50%), and no apparent homology (<10%).
Several Homology Relationships Are Evident from Partial
Amino Acid Sequence Comparisons of Ia Polypeptides. (i)
The ECQ polypeptide shows striking homology with its human
counterpart (p34). Six of the nine positions that can be com-
pared between the mouse ECk polypeptide and the human p34
polypeptide are identical. That six out of nine positions are
identical suggests that these two polypeptides are going to be
very similar, at least in their NH2-terminal regions. This ob-
servation raises several interesting points. First, homology re-
lationships have now been demonstrated between two cate-
gories of genes in the major histocompatibility complex of hu-
mans and mice-certain Ia molecules and the transplantation
antigens. Moreover, the genes encoding the transplantation
antigens and certain Ia polypeptides appear to have maintained
a close linkage within the major histocompatibility complex at
least over the period of 75 million years during which mice and
humans (i.e., mammals) have diverged from one another.
Second, the Ia homology relationship raises interesting questions
as to the location of the gene coding for the human p34 poly-
peptide. Is this gene in the HLA-D region which lies outside
the genes coding for the human transplantation antigens, or is
it located between the HLA-A and B genes? In the mouse, the
I region is located between the K and D transplantation
genes.
(ii) In contrast to the EC' polypeptide, the ECU polypeptide
shows no identical residues in the four positions that it can be,
compared with in its human counterpart, p29. This apparent
lack of homology must be treated with caution since the data
are limited. Moreover, it is possible that homology exists in other
parts of the molecules.
(iii) Both the ECk and ECU polypeptides are very different,
respectively, from the A and Ad polypeptides. The a poly-
peptides differ at each of the ten positions that can be compared
and the : polypeptides differ at each of the nine positions
compared. The fact that the Ia molecules of the I-A and I-EC
subregions are both comprised of two polypeptides of 35,000
and 28,000 molecular weights that are noncovalently associated,
and the fact that serological crossreactions have been demon-
strated between products of these two subregions (38, 39),
suggest they may have diverged from common ancestral genes.
However, if the I-A and I-EC subregion genes did share a
common ancestor, then the sites for serological crossreactivity
must be located in other parts of the molecule.
(iv) The a and f polypeptides of the I-EC subregion show
no identity over the seven residues that can be compared. A
comparison of the a and (3 molecules from the I-A region of two
different haplotypes shows 0-29% sequence identity (22).
Clearly, much more amino acid sequence data will have to be
0 4 8 12 16
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Table 2. Amino acid sequences of the a and , polypeptides of Ia molecules*
a polypeptide ,Bpolypeptide
_ouse Mouse
Mouse Human Mouse Mouse Human Guinea pig
E:Ck p34 ECk Ab Ak ECk p29 4,5 EC, Ab Ak
1 | Ile Ile Ile - - Val Gly Ile Val - -
2 Lys Asp Tyr
3 Glu Thr
4 Glu Ile Ile Pro Pro
5 (Arg) Glu Arg
6 Val Ala Ala (Arg)
7 Ile lie Ile Phe Phe
8 Ile Ile Be (Val) Phe Leu Leu Phe Val Val
or
Leu
9 Gln Val Glu Phe Tyr
10 Ala Ala Ala - Gln
11 Glu Tyr Val Phe Tyr
12 Phe Phe Phe Tyr Tyr
13 Tyr Tyr Tyr
14 FLeu Leu Leu
15 Leu Asn Leu
16 Tyr Val Val Tyr Tyr
17 Asp Tyr Tyr Tyr
18 Phe Phe Phe
19 Gln Tyr Tyr
20 Gly
21
25
26 - Tyr Tyr - Tyr
27 Tyr Tyr
28
29
30 - Tyr Tyr
*ECk polypeptides are compared independently to human and guinea pig Ia antigens and to I-A subregion products. Dashes indicate the absence
of a particular amino acid at a postion in which that amino acid has been assigned in another molecule. For example, the ECk molecule does
not have tyrosine at position 16. Accordingly, the dashes, as well as identified residues, are useful in homology comparisons. A box indicates
identical residues in two molecules. A residue in parentheses indicates some uncertainty as to its identification. Sequence data were obtained
from the following sources: human (32), guinea pig (33), and I-A subregion (22).
accumulated before the low levels of homology between a and
polypeptides in the I-A subregion and their apparent lack of
homology in the I-EC subregion can be interpreted.
(v) Finally, it should be remembered that the I region com-
prises a multigenic system in which only a few gene products
have been examined, and it is possible that, in time, new sets
of molecules may be isolated from these same subregions which
show quite different homology relationships.
New microsequence techniques are being developed that
promise to provide far more detailed sequence analyses on these
gene products. In the near future we will begin to unravel some
of the intriguing problems posed by these partial amino acid
sequence data.
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